As of 2025-07-11, the EV/EBITDA ratio of Paratek Pharmaceuticals Inc (PRTK) is -7.74. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRTK's latest enterprise value is 343.47 mil USD. PRTK's TTM EBITDA according to its financial statements is -44.39 mil USD. Dividing these 2 quantities gives us the above PRTK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.4x - 10.4x | 8.3x |
| Forward P/E multiples | 10.9x - 14.6x | 12.2x |
| Fair Price | (12.19) - (11.83) | (11.72) |
| Upside | -646.5% - -630.5% | -625.5% |
| Date | EV/EBITDA |